Combining Robotics and AI: The Emergence of Data-Driven Drug Discovery
Drug discovery is a series of decision-making steps, driven by data. Arctoris developed Ulysses, a unique platform that brings together robotics, AI, and blockchain to generate data of unprecedented quality, depth and context, at scale.

With Ulysses, Arctoris enables the right decisions at the right time, reducing cycle times, decreasing attrition rates, and making drug discovery success more likely. The Ulysses platform powers Arctoris’ internal discovery work, and is also accessible to select partners, enabling them to accelerate their programs from idea to IND, bringing new medicines to patients faster.
Date: 1 March 2022, 12:00
Venue: Zoom
Speaker: Martin-Immanuel (Bittner)
Organising department: Medical Sciences Office
Organisers: Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: David Bowkett (University of Oxford)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
Editor: Sheena Lee